Individualizing therapy for pancreatic cancer

J Gastroenterol Hepatol. 2008 Dec;23(12):1779-82. doi: 10.1111/j.1440-1746.2008.05683.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Biomarkers, Tumor / analysis*
  • CA-19-9 Antigen / analysis
  • Humans
  • Lymphatic Metastasis
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Nerve Growth Factor / analysis
  • Pancreatic Neoplasms / chemistry
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy*
  • Patient Selection*
  • Predictive Value of Tests
  • Receptor, trkA / analysis
  • Recurrence
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • CA-19-9 Antigen
  • Nerve Growth Factor
  • Receptor, trkA